Rodrigue Chatton Merck KGaA

Rodrigue Chatton holds an engineering degree specializing in micro-engineering and optics, followed by a MBA. During over eight years, he worked in teg development of medical device software and equipment, particularly in the realm of electrophysiology force sensing ablation catheters during his tenure at Endosense – St. Jude Medical. In 2015, Rodrigue transitioned to Merck KGaA, where he embarked on a journey shaping the future of connected electro-mechanical autoinjectors and their life-cycle management. His focus recently centers on leveraging transmitted data from autoinjectors, with a particular passion for unlocking the insights these data streams offer.